Chemotherapy

Many young women with newly diagnosed breast cancer have concerns regarding fertility, and these concerns may impact their treatment decisions, according to study findings published in Cancer Medicine.

Adagrasib monotherapy improved PFS and overall response rate among adults with pretreated locally advanced or metastatic non-small cell lung cancer harboring a KRASG12C

Within the past 2 decades, multiple myeloma has shifted from a highly lethal diagnosis to a condition that will no longer shorten the lifespan for many patients.

The combination of pembrolizumab and maintenance olaparib failed to significantly improve survival outcomes among adults with metastatic nonsquamous non-small cell lung cancer, according to the agent’s manufacturer.

Cisplatin chemotherapy may not reach its potential efficacy in individuals with head and neck cancer if they are exposed to secondhand smoke, according to results published in the International Journal of Molecular Sciences.

Neoadjuvant chemotherapy followed by consolidative lymphadenectomy provided a significant survival benefit among adults with locally advanced penile squamous cell carcinoma who responded to treatment, study results suggest.

The FDA granted accelerated approval to ponatinib with chemotherapy for the treatment of adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia, according to a press release.

In this video, Afsaneh Barzi, MD, PhD, discussed the phase 2 results from the NRG-GI005 (COBRA) study.

The FDA approved tislelizumab-jsgr as a monotherapy for the treatment of certain adults with unresectable or metastatic esophageal squamous cell carcinoma, according to a press release.

A novel chimeric antigen receptor T-cell therapy produced significant tumor reductions in patients with glioblastoma, results from a phase 1 trial published in The New England Journal of Medicine showed.